Sélectionner la langue
IFN-gamma R1
IFN-gamma R1 Informations sur la molécule
| Nom anglais | Interferon gamma receptor | Nombre de médicaments commercialisés | 11 |
| Nombre de médicaments cliniques | 2 | Alias de la cible | |
| Phase de R&D la plus avancée | Approved | ||
| Nom anglais | Interferon gamma receptor |
| Alias de la cible | |
| Nombre de médicaments commercialisés | 11 |
| Nombre de médicaments cliniques | 2 |
| Phase de R&D la plus avancée | Approved |
IFN-gamma R1 Liste de produits
- Attribut
Protein (2)
- Bibliothèque de produits
En ligne (2)
- Espèces
Human (2)
- Étiquette
Fc Tag (1)His Tag (1)
- Marqueur
Unconjugated (2)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
IF1-H5223 |  Human | HEK293 | Human IFN-gamma R1 / IFNGR1 Protein, His Tag |  |  |  |  Ajouter au panier |
IF1-H5254 | Human | HEK293 | Human IFN-gamma R1 / IFNGR1 Protein, Fc Tag |  | | | Ajouter au panier |
Quantité totale2
- 1
IFN-gamma R1Contexte de la molécule
Interferon gamma receptor 1 (IFNGR1) is also known as CD antigen CD119, which belongs to the type II cytokine receptor family. IFNGR1 contains two fibronectin type-III domains and two Ig-like C2-type (immunoglobulin-like) domains. IFNGR1 / CD119 is receptor for interferon gamma. Two receptors bind one interferon gamma (IFNG) dimer.
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| rSIFN-co | Phase 3 Clinical | Sichuan Huiyang Life Science and Technology Corp | Carcinoma, Hepatocellular; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Colonic Neoplasms; Colorectal Neoplasms; Coronavirus Disease 2019 (COVID-19); Hepatitis B, Chronic; Lung Neoplasms; Melanoma; Neuroendocrine Tumors; Prostatic Neoplasms | Details | |
| Interferon gamma (aerosol, IPF/ COPD), Stony Brook University School of Medicine | Phase 2 Clinical | Nostrum, Nyu Langone Medical Center, Stony Brook University School Of Medicine | Pulmonary Disease, Chronic Obstructive | Details |
Informations sur les médicaments commercialisés
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Plus ancien nom de marque | Pays d'approbation le plus ancien | Indication la plus ancienne | Société d'approbation la plus ancienne | Date d'approbation la plus ancienne | Indication | Essai clinique |
|---|---|---|---|---|---|---|---|---|---|---|
| Interferon gamma biosimilar (Livzon Pharmaceutical Group) | Approved | Livzon Pharmaceutical Group Inc | Mainland China | Arthritis, Rheumatoid | Livzon Pharmaceutical Group Inc | 1998-01-01 | Arthritis, Rheumatoid | Details | ||
| Interferon gamma (Hayashibara) | OH-6000 | Approved | Hayashibara | Ogamma | Japan | Skin Neoplasms | null | 1997-08-05 | Skin Neoplasms | Details |
| Recombinant interferon gamma (Shanghai Chemo Wanbang Biopharma) | Approved | Shanghai Kaimao Bio-Pharmaceutical Co Ltd | gamma, 伽玛 | Mainland China | Arthritis, Rheumatoid; Liver Cirrhosis | Shanghai Kaimao Bio-Pharmaceutical Co Ltd | 1998-01-01 | Arthritis, Rheumatoid; Granulomatous Disease, Chronic; Liver Cirrhosis | Details | |
| Interferon gamma-1a biosimilar (Shionogi) | S-6810 | Approved | Shionogi & Co Ltd | Imunomax-γ | Japan | Mycosis Fungoides; Carcinoma, Renal Cell; Myocardial Infarction; Communicable Diseases | Shionogi & Co Ltd | 1989-09-29 | Carcinoma, Renal Cell; Communicable Diseases; Mycosis Fungoides; Myocardial Infarction | Details |
| Interferon gamma-1b | DasKloster-1001; DasKloster-1001-01; AMG-292 | Approved | Genentech Inc | Imukin 1, Actimmune, Immukin | United States | Osteopetrosis; Granulomatous Disease, Chronic | Horizon Therapeutics Ireland Dac | 1999-02-25 | Adenocarcinoma, Mucinous; Aspergillosis; Candidemia; Colonic Neoplasms; Cystic Fibrosis; Eye Diseases, Hereditary; Friedreich Ataxia; Granulomatous Disease, Chronic; Hepatitis C, Chronic; HIV Infections; Idiopathic Pulmonary Fibrosis; Leukemia, Myeloid, Acute; Liver Cirrhosis; Lung Diseases; Macular Degeneration; Melanoma; Mycobacterium avium-intracellulare Infection; Myelodysplastic Syndromes; Osteopetrosis; Plaque psoriasis; Pneumonia; Pulmonary Aspergillosis; Pulmonary Fibrosis; Rectal Neoplasms; Retinal Degeneration; Retinal Diseases; Tuberculosis, Pulmonary; Uveitis; Uveitis, Anterior | Details |
| Interferon biosimilar (LG Life Sciences) | Approved | Lg Chemical Ltd | Leukemia | Lg Chemical Ltd | 1989-01-01 | Leukemia | Details | |||
| Interferon gamma-1a (Asubio Pharma) | SUN-4800 | Approved | Asubio | Biogamma | Japan | Mycosis Fungoides | Asubio | 1992-01-01 | Mycosis Fungoides | Details |
| Interferon gamma biosimilar (Pharmaclon) | Approved | Pharmaclon | Ingaron | Russian Federation | Tuberculosis, Pulmonary; Influenza, Human; HIV Infections; Hepatitis B; Herpes Zoster; Warts; Hepatitis C; Chlamydia Infections; Neoplasms; Respiratory Distress Syndrome, Newborn; Prostatitis | Pharmaclon | 2011-01-01 | Chlamydia Infections; Condylomata Acuminata; Hepatitis B; Hepatitis C; Herpes Zoster; HIV Infections; Influenza, Human; Lentivirus Infections; Neoplasms; Papillomavirus Infections; Prostatitis; Respiratory Distress Syndrome, Newborn; RNA Virus Infections; Tuberculosis, Pulmonary; Warts | Details | |
| Interferon Gamma (Materia Medica Holding) | Approved | Materia Medica Holding Research And Production Company | Anaferon | Bacterial Infections; Virus Diseases | Details | |||||
| Interferon gamma biosimilar (Center for Genetic Engineering and Biotechnology) | Approved | Center For Genetic Engineering And Biotechnology | Idiopathic Pulmonary Fibrosis; Tuberculosis | Details | ||||||
| Interferon gamma biosimilar (Recpharma) | Approved | Recpharma | IMMUNEX | Granulomatous Disease, Chronic; Neoplasms; Osteoporosis; Virus Diseases | Details |
- Informations sur la molécule
- Liste de produits
- Informations sur les médicaments commercialisés
- Informations sur les médicaments cliniques
Partager vers :